Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveries CONCLUSIONS: GWAS results may assist in the prioritization of medications for future psychopharmaceutical research. via https://pubmed.ncbi.nlm.nih.gov/40379965/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250529010905&v=2.18.0.post9+e462414